Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,994 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

NCT02100475

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Fresno, California, United States
  • Novo Nordisk Investigational Site Fort Lauderdale, Florida, United States
  • Novo Nordisk Investigational Site Gurnee, Illinois, United States
  • Novo Nordisk Investigational Site Lexington, Kentucky, United States
View all 60 locations
View Trial Details
Completed

A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

NCT02370537

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +6 more
Locations
  • Research Site Aarhus, Denmark
  • Research Site Frederiksberg, Denmark
  • Research Site København NV, Denmark
  • Research Site Balatonfüred, Hungary
View all 22 locations
View Trial Details
Completed

Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin

NCT00569998

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Cologne, Germany
  • Novo Nordisk Investigational Site Leverkusen, Germany
View all 23 locations
View Trial Details
Completed

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

NCT00869908

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Dhaka, Bangladesh
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

Diabetes Attitudes Wishes and Needs

NCT01507116

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +9 more
Locations
  • Novo Nordisk Investigational Site Princeton, New Jersey, United States
  • Novo Nordisk Investigational Site Algiers, Algeria
  • Novo Nordisk Investigational Site Mississauga, Canada
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
View all 17 locations
View Trial Details
Completed

Comparison of Glycemic Control Achieved With 2 Different Needles

NCT00572052

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Walnut Creek, California, United States
  • Novo Nordisk Investigational Site Berlin, New Jersey, United States
  • Novo Nordisk Investigational Site Lawrenceville, New Jersey, United States
  • Novo Nordisk Investigational Site Kettering, Ohio, United States
View Trial Details
Completed

Changing Diabetes® World Tour

NCT01437072

Conditions
Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
Locations
  • Novo Nordisk Investigational Site Paço de Arcos, Portugal
  • Novo Nordisk Investigational Site Riyadh, Saudi Arabia
  • Novo Nordisk Investigational Site Dubai, United Arab Emirates
View Trial Details
Completed

Evaluating the Use of Two Different Needles in Subjects With Diabetes

NCT00569426

Conditions
Autoimmune Diseases, Delivery Systems, Diabetes, +8 more
Locations
  • Novo Nordisk Investigational Site Cambridge, United Kingdom
  • Novo Nordisk Investigational Site Cardiff, United Kingdom
  • Novo Nordisk Investigational Site Church Village, United Kingdom
  • Novo Nordisk Investigational Site Dundee, United Kingdom
View Trial Details

Related conditions